-
1 Comment
JTEC Corporation is currently in a long term downtrend where the price is trading 10.7% below its 200 day moving average.
From a valuation standpoint, the stock is 631.1% more expensive than other stocks from the Technology sector with a price to sales ratio of 24.2.
JTEC Corporation's total revenue sank by 95.0% to $37M since the same quarter in the previous year.
Its net income has dropped by 631.2% to $-139M since the same quarter in the previous year.
Based on the above factors, JTEC Corporation gets an overall score of 0/5.
| Exchange | TSE |
|---|---|
| CurrencyCode | JPY |
| ISIN | JP3386660009 |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Beta | 1.42 |
|---|---|
| Market Cap | 6B |
| PE Ratio | 32.87 |
| Target Price | 2800 |
| Dividend Yield | None |
JTEC Corporation designs, manufactures, and sells X-ray mirrors for synchrotron facilities in Japan. The company designs, develops, manufactures, and sells automated cell culture systems, as well as automated systems in various fields. It offers support services related to regenerative medicine. The company was incorporated in 1993 and is headquartered in Ibaraki, Japan.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 3446.TSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
